Moderna Vaccine Trial
Moderna moved its candidate from the lab in cambridge massachusetts to human trials in a record setting 63 days making it the frontrunner.
Moderna vaccine trial. The purpose of this study is to test moderna s vaccine candidate that may prevent illness after exposure to the sars cov 2 virus which causes covid 19. The biotech company moderna inc. For mrna 1273 we were able to leverage our experience in vaccines to move rapidly on design and manufacture of material for the phase 1 clinical trial. The same dsmb also oversees the additional ows supported phase 3 clinical trials evaluating covid 19 vaccine candidates.
To date moderna has demonstrated positive phase 1 data readouts for 6 prophylactic vaccines h10n8 h7n9 rsv chikungunya virus hmpv piv3 and cmv. On may 18 the company announced preliminary findings. Said monday that its experimental vaccine was 94 5 effective in preventing disease according to an analysis of its clinical trial. As part of the arrangement under ows representatives from niaid barda and moderna are part of the oversight group that receives recommendations from the trial s independent dsmb.
Moderna said preliminary phase three trial data shows its coronavirus vaccine is more than 94 effective in preventing covid 19. Moderna the first company to start us clinical trials of a covid 19 vaccine on thursday finished enrolling all 30 000 of its participants.